Need professional-grade analysis? Visit stockanalysis.com
$2.78B
N/A
2,275
N/A
Opko Health Inc (OPK) trades on TA in ILS. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at ILS352.10, down 0.37% from the previous close.
Over the past year, OPK has traded between a low of ILS348.00 and a high of ILS563.50. The stock has lost 32.7% over this period. It is currently 37.5% below its 52-week high.
Opko Health Inc has a market capitalization of $2.78B.
OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to rebuild and sustain the patient's own immune system. This segment also engages in the development of Epstein Barr Virus vaccine; Rayaldee, a patented extended-release product for oral administration containing 30 mcg of a prohormone; OPK-88006 oral and injectable product to regulate blood glucose and reduce body weight; NGENLA, recombinant human growth hormone product developed for the long-term treatment of pediatric patients with growth hormone deficiency. The Diagnostics segment offers laboratory testing services, such as detection, diagnosis, evaluation, monitoring, and treatment of diseases, as well as esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare under the BioReference brand; and 4Kscore test. OPKO Health, Inc. was founded in 2006 and is headquartered in Miami, Florida.
Side-by-side comparison against top Healthcare peers.